Stay updated with breaking news from Virtual Bioconnect Conference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
Pre-market Movers In Healthcare Sector: ISR, GHSI, NMTR, Check-Cap, BBI. In the Green 1. Isoray Inc. (ISR) is up over 177% at $1.47 in pre-market hours Wednesday, following FDA 510(k) clearance for the use of C4 Imaging's Sirius positive-signal MRI Markers with the company's Cesium-131, brachytherapy seeds. Brachytherapy, or internal radiation therapy, is a cost-effective option for the treatment of prostate cancer. Isoray is the world's only producer of Cesium-131, commercially known as Cesium Blu, brachytherapy seeds. 2. Guardion Health Sciences Inc. (GHSI) is up over 47% at $0.81 in pre-m...